GEH120714 (18F) injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GEH120714 (18F) injection, covering 2017-02-24 to 2017-02-24. Get the full timeline:
Most recent: Clinical Trial Update: Assess Safety, Bio-distribution, Radiation Dosimetry and Optimize the Imaging Protocol of GEH120714 (18F) Injection in Healthy Volunteers and Participants With Relapsing and Remitting Multiple Sclerosis (rrMS). [Phase 1]